PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
15-Jul-2020 Theranica Reports Positive Study Results of Nerivio® for Chronic Migraine Patients Theranica
15-Jul-2020 Original-Research: 4basebio AG (von First Berlin Equity Research GmbH) 4basebio AG
15-Jul-2020 West Announces Third-Quarter 2020 Dividend West Pharmaceutical Services, Inc.
15-Jul-2020 Byondis Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine in Advanced Endometrial Cancer B3C newswire
15-Jul-2020 Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement Samsung Biologics
15-Jul-2020 U.S. LICENSE AGREEMENT FOR BYFAVOTM (REMIMAZOLAM) BETWEEN PAION AND COSMO ASSIGNED FROM COSMO TO ACACIA PAION AG
15-Jul-2020 Vivoryon Therapeutics AG: Vivoryon Therapeutics Announces Enrollment of First Patient in VIVIAD, European Phase 2b Alzheimer's Disease Study with Varoglutamstat (PQ912) Vivoryon Therapeutics AG
14-Jul-2020 MororphoSys's Licensee Janssen Announces Approval of Tremfya (Guselkumab) by U.S. FDA for Treatment of Adults with Active Psoriatic Arthritis MorphoSys AG
14-Jul-2020 Drägerwerk AG & Co. KGaA: preliminary result for the second quarter. Business development considerably above prior year. Drägerwerk AG & Co. KGaA
14-Jul-2020 FDA In Brief: FDA Issues Four Draft Guidances To Help Facilitate the Development of New Animal Drug Products U.S. Food and Drug Administration
14-Jul-2020 SOTIO Announces First Patient Dosed in Part B of Phase 1/1b Study with SO-C101 in Combination with Pembrolizumab in Patients with Solid Tumors B3C newswire
14-Jul-2020 Toxys Appoints Susan Swarte as New Non-Executive Board Member B3C newswire
14-Jul-2020 Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia Sciad Newswire
14-Jul-2020 Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia Invivoscribe, Inc.
14-Jul-2020 Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia Invivoscribe, Inc.
14-Jul-2020 Gerresheimer AG: Gerresheimer with strong second quarter Gerresheimer AG
14-Jul-2020 Blueprint Medicines Announces Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers Blueprint Medicines Corporation
13-Jul-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
13-Jul-2020 Stephan Sieber Awarded € 1 Million Future Insight Prize 2020 by Merck Merck KGaA
13-Jul-2020 As Cannabis Enters New Markets, New Technologies Drive Cannabis Testing Market Upwards, Bringing Real-time Certainty to All Stakeholders, From Growers to Consumers Frost & Sullivan